Moreover, if ERα were defined as a tumor suppressor based on its frequent hypermethylation, this definition would contradict its role in breast carcinogenesis and the success achieved by specifically targeting this receptor with antiestrogen therapy for breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.